Background: Local recurrence of rectal cancer (LRRC) is associated with poor survival unless curative treatment is performed. The aim of this study was to investigate predictive factors for treatment with curative intent in patients with LRRC. 
Introduction
The rate of local recurrence of rectal cancer (LRRC) has decreased considerably during recent decades. As a result of improvements in surgical technique with the introduction of total mesorectal excision (TME), and the addition of preoperative radiotherapy in selected patients, the LRRC rate has dropped from 30-40 per cent in the pre-TME era to 5-9 per cent today 1 -3 . Although fewer patients develop LRRC, the prognosis is poor in those who do, with an overall 5-year survival rate of less than 10 per cent 4, 5 . Complete surgical resection of the LRRC is essential for cure and 5-year survival rates of 40-57 per cent have been reported after radical resections 4, 6, 7 . However, many patients diagnosed with LRRC will not undergo surgery owing to the presence of concomitant metastases and the challenges of achieving a complete (R0) resection 8 -10 . Factors predicting whether patients with LRRC are treated with curative or palliative intent have not been explored in detail. Previous studies 11 -13 have reported that patients are selected disproportionately for preoperative treatment of the primary rectal cancer based on age, sex and socioeconomic status. Factors related to both the primary tumour and the LRRC may influence the selection of patients for surgical resection of the recurrent tumour 9 . The aim of this study was to investigate whether curative or palliative treatment intent can be predicted by characteristics of the patient, the primary tumour or the LRRC. Data from SCRCR on patients fulfilling primary inclusion criteria n = 556
Final study cohort n = 426
Excluded: no evidence of recurrence n = 6411
Excluded: distant metastases only, or distant metastases before or simultaneously with local recurrence n = 2193
Excluded n = 130 Medical notes missing n = 32 Stage IV disease at primary sugery or non-radical primary surgery n = 98 
Methods
The Swedish Colorectal Cancer Registry (SCRCR) is a national quality registry, founded in 1995, and includes data on patient characteristics and details of treatment of the primary tumour, such as tumour height, type of surgery performed, radicality, and neoadjuvant and adjuvant treatments. The registry has been validated several times, confirming the data to be highly reliable with regard to trends and patterns of rectal cancer management and outcomes 14 -16 . More than 97 per cent of patients diagnosed with rectal cancer are reported to the registry 17 . Since 2008, national treatment guidelines including a follow-up programme have been used for patients having surgery for primary rectal cancer, whereas patients in the present study were followed according to local routines 18 .
Follow-up details on local and distant recurrences are reported by the surgeon to the SCRCR at 1, 3 and 5 years, and date of death was obtained from the Cause of Death Registry, based on a unique personal identity number. Although the diagnosis of LRRC or distant metastases is reported to the registry, there is no information about further management of the recurrent disease.
Study population
For the purpose of this study, all patients who underwent abdominal resection for primary rectal cancer in Sweden between 1 January 1995 and 31 December 2002, and with a subsequent diagnosis of LRRC within 5 years (until 2007), were identified from the SCRCR. Patients with distant metastases, diagnosed before or simultaneously with the LRRC, were excluded. To retrieve information about further management of patients with LRRC, medical records of all patients were collected and scrutinized according to a specific protocol. Information collected on the LRRC included symptoms at diagnosis, assessment of local and distant disease, location, intention of treatment, type of treatment, surgical techniques, radicality, neoadjuvant or adjuvant treatments, postoperative complications and co-morbidity. Data retrieval from medical records and completion of the protocols was performed by one of the authors.
After completion of data collection from the medical records, patients who had stage IV disease at the time of primary surgery and those in whom the primary surgery had been non-radical (R2) were excluded. Patients whose tumours did not fulfil the stated definition of a LRRC were also excluded. The study was approved by the Regional Ethics Committee in Stockholm, Sweden. as distant metastasis unless it was the result of a local overgrowth.
A combination of the Memorial Sloan-Kettering and the Leeds classifications was used to describe the location of the LRRC 19, 20 . The recurrences were categorized as axial, anterior, posterior or lateral. Axial recurrences were tumours growing at the anastomotic site or in the perineum; anterior tumours were growing into the internal genital organs or the urinary tract; a posterior location meant growth into the sacrum or the presacral area; and a lateral location included growth into the pelvic side wall or the lateral bony pelvis. Recurrences with an axial or anterior location only, or a combination of the two, were defined as central, whereas those with a solely posterior or lateral location, or both combined, were termed posterolateral. Recurrences with a combined location in central and posterolateral areas were classified as multifocal. In further analyses, tumours with a posterolateral, multifocal or unspecified location were grouped together as non-central recurrences. Treatment intent was classified based on information in the medical records. If the intention was unclear, it was regarded as palliative.
Statistical analysis
Associations between clinical factors and treatment intent were estimated using logistic regression models. The results are expressed as odds ratios with 95 per cent confidence intervals for treatment with palliative intent compared with treatment with curative intent. Survival time was defined as the time between diagnosis of LRRC 21 . Overall survival was calculated using the Kaplan-Meier method and differences in survival were tested using the log rank test. A Cox regression model was used to estimate crude and adjusted hazard ratios for death, together with 95 per cent confidence intervals. The proportionality of the hazard functions across co-variable patterns was inspected visually and tested with Shoenfeld's residuals 22 . All statistical tests were two-sided and statistical significance was set at α = 0⋅05. The analyses were carried out in Stata ® version 12 (StataCorp, College Station, Texas, USA).
Results
The study included a total of 426 patients (Fig. 1) . Data on characteristics of the primary disease and LRRC are shown in Tables 1 and 2 . Symptoms related to the LRRC were present in 360 patients (84⋅5 per cent); pain, anal and perianal symptoms, or a palpable tumour were the most common symptoms. Vaginal secretion or bleeding occurred as the first symptom in 32 of the women (16⋅4 per cent). Only 61 patients (14⋅3 per cent) were asymptomatic and recurrence was diagnosed during planned follow-up visits. Radiological assessment of the LRRC with CT and/or MRI was undertaken in 339 patients (79⋅6 per cent). The radiological examinations were performed either as part of a surveillance programme or after the onset of symptoms.
The LRRC was located centrally in 213 patients (50⋅0 per cent), including 150 (35⋅2 per cent) with recurrence at the anastomotic site or in the perineum only. The tumour had a posterolateral location in 65 patients (15⋅3 per cent), including a solely lateral location in 16 (3⋅8 per cent). A total of 123 patients (28⋅9 per cent) had multifocal LRRC.
Predictors of treatment intent
Some 149 patients (35⋅0 per cent) received treatment with curative intent and 277 (65⋅0 per cent) had treatment with palliative intent; the latter included 193 patients who received active palliative treatment and 84 who received no active tumour-directed therapy.
Associations between patient and primary tumour characteristics and treatment intent in patients with LRRC are shown in Table 1 . Factors associated with palliative treatment in both the univariable and multivariable models were old age, abdominal perineal resection (APR) or Hartmann's procedure as primary surgery, and stage III primary tumour. Previous surgery with APR was the strongest predictive factor for palliative treatment in this analysis. An R1 resection at primary surgery was significantly more common among patients treated with palliative intent in the univariable analysis, but not in the multivariable model.
Associations between patient and LRRC characteristics and treatment intent are presented in Table 2 . Old age, symptoms at diagnosis, presence of hydronephrosis, and non-central location of the LRRC were associated with palliative treatment intent in the univariable model and after adjustment in the multivariable model. Age 80 years or more at time of diagnosis of LRRC was the strongest predictive factor for treatment with palliative intent. The presence of co-morbidity was not associated with treatment intention.
Follow-up data and survival following treatment of recurrence
Median follow-up was 8⋅6 years for all patients, calculated from the date of diagnosis of LRRC. The minimum follow-up time for surviving patients was 2⋅0 years and the maximum was 12⋅3 years. Median survival from the date of diagnosis of LRRC was 1⋅1 (range 0-12⋅3) years and the 5-year overall survival rate was 8⋅9 per cent. There was a statistically significant difference in 5-year survival between patients treated with curative intent and those treated with palliative intent (23⋅1 versus 1⋅0 per cent respectively; P < 0⋅001).
Hazard ratios for selected variables related to the LRRC in patients treated with curative intent are shown in Table 3 . There was a significant increase in risk of death in patients aged 80 years and older, those with symptoms, those with hydronephrosis and patients with a non-central LRRC. The presence of co-morbidity had no influence on the risk of death among patients treated with curative intent.
Discussion
In the present study, young age, a less advanced primary tumour, previous surgery with low anterior resection, absence of symptoms and central location of the LRRC were all positive predictive factors for treatment with curative intent in patients with LRRC.
Although better surgery and neoadjuvant treatments have substantially improved local control after rectal cancer surgery, some patients still develop recurrence. The treatment of these patients is challenging. Different patient-and tumour-related aspects have to be considered in the treatment decisions, where a potential chance of cure has to be weighed against potentially severe morbidity related to extensive surgical procedures. In primary rectal cancer, the introduction of multidisciplinary team (MDT) conferences has optimized treatment decisions and contributed to improved survival 23, 24 . MDT conferences may play an even more important role in patients with LRRC as the presentation differs widely between individuals, guidelines are of limited value, and more individualized management is necessary. As regular MDT conferences were not established in most Swedish hospitals during the study period, it may be inferred that the majority of patients in this study were not discussed at such meetings.
Only one-third of all patients were treated with curative intent and this proportion corresponds to findings of other population-based studies 4, 5, 25 . There were, however, considerable differences in this rate between hospitals (data not shown) and it may be that treatment with curative intent is undertaken more often in higher-volume centres. Since 2008, there have been Swedish national guidelines concerning the management of rectal cancer, including LRRC, and since 2016 these have also included a recommendation for early patient referral to a highly specialized centre.
Only one in six of the LRRCs were asymptomatic and detected at surveillance visits in this study. It would be interesting to determine whether CT/MRI surveillance would result in potentially curative treatment being offered to more patients 26 . Old patients, those with distal or T3-T4 primary tumours, and patients who had an APR or Hartmann's procedure at primary surgery were more likely receive palliative treatment for the LRRC. The presence of symptoms and hydronephrosis were other factors associated with palliative treatment intent in this study. The presence of symptoms, especially pain, at the time of diagnosis of the LRRC indicates a more advanced tumour that may be less likely to be curable 27, 28 . Central recurrences after low anterior resection are often detected earlier owing to rectal or vaginal bleeding, and can usually be excised with an R0 resection. Central recurrences can often be resected for cure by further resection of the remaining bowel and mesorectum or by pelvic exenteration, whereas non-central recurrence may require sacral resection, lateral pelvic side-wall clearance or even hemipelvectomy to achieve an R0 resection. This surgery is complex, demanding and suitable only for fit patients in highly specialized centres 29 .
The main strength of this study is the large populationbased national patient cohort with long follow-up. All patients with LRRC reported to the SCRCR during the study period were included, which eliminates the risk of selection bias. Information from the medical records was used as a complementary source to create a database with validated registry data concerning the primary tumour and detailed information on the LRRC in each patient.
There are also some limitations. The patients were identified through a national quality registry and it is possible that some cases may have been missed owing to under-reporting. However, the registry has been validated on several occasions and the number of patients with unreported LRRC is likely to be low. Because of the retrospective design of the study, the possibility of information bias cannot be ruled out. To ensure proper follow-up time after treatment of LRRC, the included patients were diagnosed with recurrence before 2008. Advances in the management of recurrent rectal cancer, including centralization in high-volume centres, have been made since then. However, this study has defined patients who can be managed with curative intent, the success of which supports the selection process, even for the time interval examined. Better selection, improved therapies and centralized surgical management should continue to improve outcomes for LRRC.
